Published in PLoS One on January 16, 2013
Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine. Theranostics (2015) 0.87
Aptamers: A promising chemical antibody for cancer therapy. Oncotarget (2016) 0.77
SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer. Int J Nanomedicine (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med (2004) 49.02
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (1990) 35.96
In vitro selection of RNA molecules that bind specific ligands. Nature (1990) 30.19
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med (2003) 14.59
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov (2004) 9.96
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell (1993) 7.14
Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem (1994) 6.18
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood (1996) 5.31
Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem (1999) 5.22
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem (1992) 4.92
The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer (2003) 4.75
Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med (1992) 4.39
The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci (2001) 3.54
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry (2004) 3.41
Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. J Clin Oncol (2010) 3.32
Circular dichroism and conformational polymorphism of DNA. Nucleic Acids Res (2009) 3.20
The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem (1996) 2.75
JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res (2004) 2.59
An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A (2009) 2.59
Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J Med Chem (1993) 2.34
Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood (2001) 2.27
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol (2009) 2.25
Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene (2005) 2.24
Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J Cell Biochem (2010) 1.93
Direct in vitro selection of a 2'-O-methyl aptamer to VEGF. Chem Biol (2005) 1.68
Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer (2005) 1.64
Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. Oncologist (2007) 1.58
VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. Br J Cancer (2008) 1.55
Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ (2001) 1.47
Let's get specific: the relationship between specificity and affinity. Chem Biol (1995) 1.43
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol (2001) 1.41
Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res (2009) 1.32
Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer (2000) 1.30
Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet (1995) 1.23
Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia (2009) 1.21
Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer. Clin Ther (2005) 1.20
Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells. Cancer Res (2008) 1.18
High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2'-amino-modified RNA. Nucleic Acids Res (1996) 1.06
Efficacy and cardiac safety of adjuvant trastuzumab-based chemotherapy regimens for HER2-positive early breast cancer. Ann Oncol (2010) 1.05
Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution. Nucleic Acids Res (1991) 1.03
Cetuximab: a review of its use in squamous cell carcinoma of the head and neck. Drugs (2010) 1.03
Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL). J Thorac Oncol (2010) 1.02
Probing high affinity sequences of DNA aptamer against VEGF165. PLoS One (2012) 0.96
Conjugation to polyethylene glycol polymer promotes aptamer biodistribution to healthy and inflamed tissues. Oligonucleotides (2005) 0.96
Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein. Bioorg Med Chem Lett (2008) 0.92
Experimental hypoxia is a potent stimulus for radiotracer uptake in vitro: comparison of different tumor cells and primary endothelial cells. Cancer Lett (2007) 0.88
Expression of Jagged1 and its association with hepatitis B virus X protein in hepatocellular carcinoma. Biochem Biophys Res Commun (2007) 0.88
[Expression and significance of Notch1, Jagged1 and VEGF in human non-small cell lung cancer]. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2007) 0.87
Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed hep G2 cells. Am J Physiol (1999) 0.83
Combinatorial selection and delivery of thioaptamers. Biochem Soc Trans (2007) 0.82
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol (2005) 2.16
Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res (2003) 1.94
Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology (2014) 1.60
Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials (2010) 1.44
Singapore's anatomical future: quo vadis? Anat Sci Educ (2012) 1.39
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy. Breast Cancer Res (2011) 1.37
Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis (2002) 1.32
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest (2012) 1.29
Nanoparticle-induced pulmonary toxicity. Exp Biol Med (Maywood) (2010) 1.28
Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. Mod Pathol (2005) 1.20
Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin). J Biol Chem (2012) 1.19
Breast cancer metastasis. Cancer Genomics Proteomics (2012) 1.18
Heat shock proteins as novel therapeutic targets in cancer. In Vivo (2008) 1.13
Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer. Int J Oncol (2005) 1.05
Gold nanoparticles in cancer therapy. Acta Pharmacol Sin (2011) 1.02
Scorpion venoms as a potential source of novel cancer therapeutic compounds. Exp Biol Med (Maywood) (2014) 1.01
Significance of the Y-box proteins in human cancers. J Mol Genet Med (2005) 0.97
Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol (2003) 0.96
Over-expression of metallothionein predicts chemoresistance in breast cancer. J Pathol (2009) 0.96
Probing high affinity sequences of DNA aptamer against VEGF165. PLoS One (2012) 0.96
Current studies into the genotoxic effects of nanomaterials. J Nucleic Acids (2010) 0.95
Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Mod Pathol (2008) 0.95
Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant. Am J Pathol (2003) 0.94
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Mod Pathol (2010) 0.94
Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner. Am J Physiol Cell Physiol (2002) 0.94
Cell cycle arrest induced by hydrogen peroxide is associated with modulation of oxidative stress related genes in breast cancer cells. Exp Biol Med (Maywood) (2009) 0.93
Differential reactions of microglia to brain metastasis of lung cancer. Mol Med (2006) 0.92
On-chip measurements of cell compressibility via acoustic radiation. Lab Chip (2011) 0.90
Greek anatomist herophilus: the father of anatomy. Anat Cell Biol (2010) 0.90
Y-Box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer. Mod Pathol (2008) 0.90
The induction of epigenetic regulation of PROS1 gene in lung fibroblasts by gold nanoparticles and implications for potential lung injury. Biomaterials (2011) 0.89
Genomic instability of gold nanoparticle treated human lung fibroblast cells. Biomaterials (2011) 0.89
Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res (2004) 0.88
Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring. J Trauma (2003) 0.88
Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer. Cancer Lett (2005) 0.88
Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling. Autophagy (2015) 0.87
Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle. Int J Oncol (2010) 0.87
Claudins and gastric carcinogenesis. Exp Biol Med (Maywood) (2013) 0.87
Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells. Cancer Lett (2008) 0.87
p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod Pathol (2005) 0.87
Zinc supplementation prevents cardiomyocyte apoptosis and congenital heart defects in embryos of diabetic mice. Free Radic Biol Med (2012) 0.87
Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer. Int J Oncol (2003) 0.87
Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cells. J Biol Chem (2010) 0.87
Effect of fixation period on HER2/neu gene amplification detected by fluorescence in situ hybridization in invasive breast carcinoma. J Histochem Cytochem (2002) 0.86
Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells. Cell Immunol (2011) 0.86
Cardiac malformations are associated with altered expression of vascular endothelial growth factor and endothelial nitric oxide synthase genes in embryos of diabetic mice. Exp Biol Med (Maywood) (2008) 0.86
A novel antiestrogenic mechanism in progesterone receptor-transfected breast cancer cells. J Biol Chem (2005) 0.86
Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells. Breast Cancer Res Treat (2007) 0.85
A liquid crystal-based sensor for real-time and label-free identification of phospholipase-like toxins and their inhibitors. Biosens Bioelectron (2008) 0.85
Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy. Curr Clin Pharmacol (2006) 0.85
Silencing the Metallothionein-2A gene induces entosis in adherent MCF-7 breast cancer cells. Anat Rec (Hoboken) (2010) 0.84
Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA. Am J Pathol (2003) 0.84
A novel anti-apoptotic role for apolipoprotein L2 in IFN-γ-induced cytotoxicity in human bronchial epithelial cells. J Cell Physiol (2011) 0.84
Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn J Cancer Res (2002) 0.84
Targeting heparan sulfate proteoglycans in breast cancer treatment. Recent Pat Anticancer Drug Discov (2008) 0.84
Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer. Int J Oncol (2010) 0.83
Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment. Int J Pharm (2013) 0.83
Differences in collagen production between normal and keloid-derived fibroblasts in serum-media co-culture with keloid-derived keratinocytes. J Dermatol Sci (2002) 0.83
Prognostic association of YB-1 expression in breast cancers: a matter of antibody. PLoS One (2011) 0.83
Comparison of the effects of differentially sulphated bovine kidney- and porcine intestine-derived heparan sulphate on breast carcinoma cellular behaviour. Int J Oncol (2007) 0.82
Differential expression of metallothionein in gastrointestinal stromal tumors and gastric carcinomas. Anat Rec (Hoboken) (2010) 0.82
Localized surface plasmon resonance: a unique property of plasmonic nanoparticles for nucleic acid detection. Nanoscale (2013) 0.82
Drosophila melanogaster as a model organism to study nanotoxicity. Nanotoxicology (2014) 0.82
Increased expression of non-sulfated chondroitin correlates with adverse clinicopathological parameters in prostate cancer. Mod Pathol (2008) 0.82
Endogenous expression of interleukin-8 and interleukin-10 in nasopharyngeal carcinoma cells and the effect of photodynamic therapy. Int J Mol Med (2002) 0.81
Quantum dot capped magnetite nanorings as high performance nanoprobe for multiphoton fluorescence and magnetic resonance imaging. J Am Chem Soc (2010) 0.81
Imaging the disruption of phospholipid monolayer by protein-coated nanoparticles using ordering transitions of liquid crystals. Biomaterials (2008) 0.81
Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors. Mod Pathol (2006) 0.80
Downregulation of ER60 protease inhibits cellular proliferation by inducing G1/S arrest in breast cancer cells in vitro. Anat Rec (Hoboken) (2012) 0.79
Toxicological profile of small airway epithelial cells exposed to gold nanoparticles. Exp Biol Med (Maywood) (2013) 0.79
Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model. Int J Oncol (2003) 0.79
Dimeric gold nanoparticle assembly for detection and discrimination of single nucleotide mutation in Duchenne muscular dystrophy. Biosens Bioelectron (2010) 0.79
Rapid and label-free single-nucleotide discrimination via an integrative nanoparticle-nanopore approach. ACS Nano (2012) 0.79
Serglycin in health and diseases. Anat Rec (Hoboken) (2012) 0.78
Surmounting chemoresistance by targeting the Y-box binding protein-1. Anat Rec (Hoboken) (2011) 0.78
Controlled microscale diffusion gradients in quiescent extracellular fluid. Biomed Microdevices (2010) 0.78
Modulation of metallothionein isoforms is associated with collagen deposition in proliferating keloid fibroblasts in vitro. Exp Dermatol (2010) 0.78
Correlation of p53 and cerbB2 expression and hormonal receptor status with clinicopathologic parameters in ductal carcinoma in situ of the breast. Oncol Rep (2002) 0.78
Modulation of Matrix metalloproteinase-1 in nasopharyngeal cancer cells by photoactivation of hypericin. Int J Oncol (2004) 0.78
Transcriptome profiling of murine spinal neurulation using laser capture microdissection and high-density oligonucleotide microarrays. Methods Mol Biol (2011) 0.77
Targeting metallothionein for prognosis and treatment of breast cancer. Recent Pat Anticancer Drug Discov (2011) 0.77
Inducible nitric oxide synthase and bcl-2 expression in nasopharyngeal cancer: correlation with outcome of patients after radiotherapy. Int J Radiat Oncol Biol Phys (2003) 0.77
Glutathione S-transferase pi expression in nasopharyngeal cancer. Arch Otolaryngol Head Neck Surg (2002) 0.77
Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo. Int J Mol Med (2005) 0.77
Heat shock proteins and neurodegenerative disorders. ScientificWorldJournal (2008) 0.76
Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survival. J Clin Pathol (2010) 0.76
Function of sirtuins in biological tissues. Anat Rec (Hoboken) (2009) 0.76
Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin. Oncol Rep (2006) 0.76
Detection of HER2/neu gene amplification in archival paraffin-embedded breast cancer tissues by fluorescence in situ hybridization. Histochem Cell Biol (2003) 0.75
The effect of cholesterol on protein-coated gold nanoparticle binding to liquid crystal-supported models of cell membranes. Biomaterials (2010) 0.75
Differential expression of metallothionein isoforms in nasopharyngeal cancer and inhibition of cell growth by antisense down-regulation of metallothionein-2A. Oncol Rep (2005) 0.75